Literature DB >> 1553037

MRI of pituitary macroadenomas with reference to hormonal activity.

P Lundin1, R Nyman, P Burman, P O Lundberg, C Muhr.   

Abstract

In 115 patients with pituitary macroadenomas, the findings on mid-field MRI were correlated with the hormonal activity of the tumours. Adenomas secreting growth hormone (GH), prolactin (PRL) and clinically nonsecretory adenomas were studied. Tumour size, invasiveness and signal intensity patterns were recorded. Relaxation times and ratios of signal intensity and proton density (relative to the corpus callosum) were analysed in areas of apparently solid tissue in a subgroup of 59 previously untreated patients. Invasiveness was more common in PRL- and GH-secreting adenomas than in the nonsecreting ones. Diffuse invasion of the base of the skull was most common in prolactinomas, and associated with a lower frequency of suprasellar tumour extension. In prolactinomas, a correlation was found between the maximum serum PRL level and tumour size. Haemorrhagic, cystic or necrotic areas were less common in GH-secreting tumours than in the other types. Haemorrhage was more common in prolactinomas than in nonsecreting tumours. MR parameters were similar in prolactinomas and nonsecreting adenomas, but indicated a smaller amount of water in GH-secreting tumours.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1553037     DOI: 10.1007/bf00588432

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  35 in total

1.  Electron microscopical morphometry of pituitary adenomas. Comparison of tumours in acromegaly and hyperprolactinemia.

Authors:  W Saeger; P Kant; J Caselitz; D K Lüdecke
Journal:  Pathol Res Pract       Date:  1988-02       Impact factor: 3.250

2.  Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature.

Authors:  R L Kamman; K G Go; W Brouwer; H J Berendsen
Journal:  Magn Reson Med       Date:  1988-03       Impact factor: 4.668

3.  Reproducibility of T1 and T2 relaxation times calculated from routine MR imaging sequences: phantom study.

Authors:  B O Kjos; R L Ehman; M Brant-Zawadzki
Journal:  AJR Am J Roentgenol       Date:  1985-06       Impact factor: 3.959

4.  T1 and T2 measurements on a 1.5-T commercial MR imager.

Authors:  R K Breger; A A Rimm; M E Fischer; R A Papke; V M Haughton
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

5.  A decade of pituitary microsurgery. The Herbert Olivecrona lecture.

Authors:  C B Wilson
Journal:  J Neurosurg       Date:  1984-11       Impact factor: 5.115

6.  MR imaging of cavernous sinus involvement by pituitary adenomas.

Authors:  G Scotti; C Y Yu; W P Dillon; D Norman; N Colombo; T H Newton; J De Groot; C B Wilson
Journal:  AJR Am J Roentgenol       Date:  1988-10       Impact factor: 3.959

7.  Suprasellar lesions: evaluation with MR imaging.

Authors:  M G Karnaze; K Sartor; J D Winthrop; M H Gado; F J Hodges
Journal:  Radiology       Date:  1986-10       Impact factor: 11.105

8.  Pituitary apoplexy: its incidence and clinical significance.

Authors:  S Wakai; T Fukushima; A Teramoto; K Sano
Journal:  J Neurosurg       Date:  1981-08       Impact factor: 5.115

9.  Haemorrhage into pituitary adenomas.

Authors:  S Mohanty; P N Tandon; A K Banerji; B Prakash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-10       Impact factor: 10.154

10.  MR of craniopharyngiomas: tumor delineation and characterization.

Authors:  E Pusey; K E Kortman; B D Flannigan; J Tsuruda; W G Bradley
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

View more
  8 in total

1.  Aggressive giant pituitary adenoma presenting as a nasopharyngeal mass: magnetic resonance imaging and pathologic findings.

Authors:  T P Ravichandran; R Bakshi; R R Heffner; K J Gibbons; V E Bates; D J Durante; W R Kinkel
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.

Authors:  Giovanna Aparecida Balarini Lima; Evelyn de Oliveira Machado; Cintia Marques Dos Santos Silva; Paulo Niemeyer Filho; Mônica Roberto Gadelha
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

3.  Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.

Authors:  Sema Ciftci Dogansen; Gulsah Yenidunya Yalin; Seher Tanrikulu; Sakin Tekin; Nihan Nizam; Bilge Bilgic; Serra Sencer; Sema Yarman
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

4.  Evaluation of diffusivity in pituitary adenoma: 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation.

Authors:  Akio Hiwatashi; Osamu Togao; Koji Yamashita; Kazufumi Kikuchi; Makoto Obara; Takashi Yoshiura; Hiroshi Honda
Journal:  Br J Radiol       Date:  2016-05-17       Impact factor: 3.039

5.  Geometric survey on magnetic resonance imaging of growth hormone producing pituitary adenoma.

Authors:  Yuriz Bakhtiar; Ryosuke Hanaya; Hiroshi Tokimura; Hirofumi Hirano; Tatsuki Oyoshi; Shingo Fujio; Manoj Bohara; Kazunori Arita
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

6.  [Spinal cord infarction].

Authors:  N Naumann; K Shariat; S Ulmer; C Stippich; F J Ahlhelm
Journal:  Radiologe       Date:  2012-05       Impact factor: 0.635

7.  The utility of dynamic MRI in differentiating the hormone-producing ability of pituitary adenomas.

Authors:  Taishi Amano; Tomohiko Masumoto; Hiroyoshi Akutsu; Noriaki Sakamoto; Sodai Hoshiai; Kensaku Mori; Takahito Nakajima
Journal:  Jpn J Radiol       Date:  2021-04-21       Impact factor: 2.374

8.  Associations of Ki-67 Labeling Index with Clinical and Paraclinical Features of Growth Hormone-Secreting Pituitary Adenomas: A Single Center Report from Iran.

Authors:  Shahrzad Mohseni; Maryam Aboeerad; Farshad Sharifi; Seyed Mohammad Tavangar; Mohammadreza Mohajeri-Tehrani
Journal:  Int J Endocrinol Metab       Date:  2019-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.